HUTCHMED (China) Ltd. (HCM)
14.04
+0.37
(+2.71%)
USD |
NASDAQ |
Oct 09, 12:12
HUTCHMED Enterprise Value : 1.500B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.500B |
| October 07, 2026 | 1.607B |
| October 06, 2026 | 1.662B |
| October 05, 2026 | 1.612B |
| October 02, 2026 | 1.593B |
| October 01, 2026 | 1.657B |
| September 30, 2026 | 1.668B |
| September 29, 2026 | 1.584B |
| September 28, 2026 | 1.580B |
| September 25, 2026 | 1.547B |
| September 24, 2026 | 1.540B |
| September 23, 2026 | 1.622B |
| September 22, 2026 | 1.570B |
| September 21, 2026 | 1.641B |
| September 18, 2026 | 1.500B |
| September 17, 2026 | 1.526B |
| September 16, 2026 | 1.463B |
| September 15, 2026 | 1.521B |
| September 14, 2026 | 1.498B |
| September 11, 2026 | 1.352B |
| September 10, 2026 | 1.404B |
| September 09, 2026 | 1.483B |
| September 08, 2026 | 1.537B |
| September 04, 2026 | 1.573B |
| September 03, 2026 | 1.577B |
| Date | Value |
|---|---|
| September 02, 2026 | 1.216B |
| September 01, 2026 | 1.193B |
| August 31, 2026 | 1.230B |
| August 28, 2026 | 1.275B |
| August 27, 2026 | 1.281B |
| August 26, 2026 | 1.270B |
| August 25, 2026 | 1.254B |
| August 24, 2026 | 1.240B |
| August 21, 2026 | 1.319B |
| August 20, 2026 | 1.306B |
| August 19, 2026 | 1.312B |
| August 18, 2026 | 1.320B |
| August 17, 2026 | 1.306B |
| August 14, 2026 | 1.244B |
| August 13, 2026 | 1.237B |
| August 12, 2026 | 1.252B |
| August 11, 2026 | 1.291B |
| August 10, 2026 | 1.305B |
| August 07, 2026 | 1.298B |
| August 06, 2026 | 1.179B |
| August 05, 2026 | 1.130B |
| August 04, 2026 | 1.134B |
| August 03, 2026 | 1.130B |
| July 31, 2026 | 1.057B |
| July 30, 2026 | 994.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| GSK Plc | 113.60B |
| Sino Biopharmaceutical Ltd. | 13.89B |
| Regent Pacific Group Ltd. | -- |
| SSY Group Ltd. | -- |
| Beijing Tong Ren Tang Chinese Medicine Co., Ltd. | 314.83M |
Enterprise Value Related Metrics
| Earnings Yield | 0.72% |
| Normalized Earnings Yield | 0.9801 |